Visser, Edith http://orcid.org/0000-0003-0885-7722
de Jong, Kim http://orcid.org/0000-0002-3948-1046
Pepels, Janneke J. S.
Kerstjens, Huib A. M. http://orcid.org/0000-0001-7705-7927
ten Brinke, Anneke
van Zutphen, Tim http://orcid.org/0000-0003-3325-9708
Funding for this research was provided by:
Teva Pharmaceutical Industries
Stichting Longgeneeskunde Fryslân
Article History
Received: 7 March 2022
Accepted: 12 January 2023
First Online: 4 February 2023
Declarations
:
: HK reports grants and fees for advisory boards and lectures from AstraZeneca, Boerhinger Ingelheim, Chiesi and GSK, all paid to his institution and outside of the submitted work. AB reports grants from AstraZeneca, GSK and TEVA, fees for advisory boards and lectures from AstraZeneca, GSK, Novartis, TEVA and SanofiGenzyme, outside the submitted work. All other authors declare that they have no conflict of interest.
: The Lifelines Cohort Study has been approved by the medical ethics committee of the UMCG (no. 2007/152) and has been ISO certified (9001:2008 Healthcare). Informed consent was obtained from all individual participants included in the Lifelines Cohort Study.